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Accepted 18 April 2014Fig. 1. Histopathology shows atypical lymphoid cell inﬁltrate with an angiodestructive
growth pattern (hematoxylineeosin stain, 200).A 62-year-old man with hypertension and diabetes presented
with rhinorrhea, blood-tinged nasal discharge, intermittent fever,
and body weight loss of more than 10 kg over 3 months. He had
visited local clinics several times and had been treated under the
diagnosis of chronic rhinosinusitis. The condition did not improve,
and so he came to our clinic for help. Laboratory data were within
reference levels. Computed tomography revealed chronic rhinosi-
nusitis. Nasal cavity, sinus, and nasopharyngeal biopsies were
performed. Histopathology showed variably sized atypical
lymphoid cells with irregular nuclei inﬁltrate in the stroma, an
angiodestructive growth pattern, and necrosis (Fig. 1). Immuno-
histochemically, these cells were positive for CD3 and CD56 (Fig. 2).
EpsteineBarr virus (EBV) in situ hybridization was positive in the
tumor cells (Fig. 2, inset). Nasal-type natural killer/T (NK/T)-cell
lymphoma was diagnosed. EBV serology revealed positive results
for EBV viral capsid antigen immunoglobulin G and EBV nuclear
antigen immunoglobulin G. The patient received chemotherapy.
Nasal-type NK/T-cell lymphoma is an aggressive lymphoma and
is prevalent in Asia, and Central and South America. It occurs most
commonly in the upper aerodigestive tract; however, extranasal
sites can also be involved. The key diagnostic features are poly-
morphous lymphoid inﬁltrate with angioinvasion, demonstration
of an NK/T-cell immunophenotype, and EBV in the tumor cells. The
prognosis is mainly related to the location and stage of the tumor at
diagnosis. An overall poor outcome has been noted in historical
series. For patients with localized disease (stage I or II), combined
modality therapy with radiation and chemotherapy isFig. 2. Immunostaining with CD56. The inset shows EpsteineBarr encoding region in
situ hybridization.
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disseminated disease (stage III or IV) is uncertain, and clinical trials
are ongoing.Further reading
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